Oncology Rounds

Recent Posts

Starting a CT lung cancer screening program

on July 9, 2012  |  Permalink

Topics: Oncology, Service Lines, CT, Imaging, Lung Cancer, Tumor Site Strategy, Business Development, Strategy

Brian Clement, Oncology Roundtable

At the annual meeting of the International Society for Computed Tomography (ISCT), Dr. Jared Christensen, Duke Medicine's director of radiology for the newly-established CT lung cancer screening program, presented advice for other organizations that are considering developing such a program.

Continue reading:
Starting a CT lung cancer screening program

What's driving PET/CT growth?

on May 31, 2012  |  Permalink

Topics: Oncology, Service Lines, Imaging, PET, CT

Brian Clement, Oncology Roundtable

Our Technology Insights program has projected that PET/CT utilization will grow 22% over the next five years and 55% over the next ten years. Technological advances, demographic trends, decreasing price points, and reimbursement changes are driving this projected growth.

Continue reading:
What's driving PET/CT growth?

New Data from the NCI Indicates CT Scans Can Reduce Lung Cancer Deaths

on November 4, 2010  |  Permalink

Topics: Screening and Prevention, Methodologies, Performance Improvement, CT, Imaging, Service Lines, Oncology

According to the NY Times, data has just come in from the NCI that indicates CT scans can reduce lung cancer deaths. The data comes from the National Lung Cancer Screening Trial which evaluated more than 53,000 current and former heavy smokers between the ages of 55 and 74 given either a standard chest x-ray or a low dose CT scan. Scans were provided at the start of the trial and then twice more over two years, and participants were then followed for five years. 354 patients receiving a CT scan died compared to 442 who received X-rays.

The study is not without controversy - not surprising given the heated debate that's surrounded this topic for years. Proponents of CT scans believe the results would have been stronger had scanning continued beyond the two year mark, while others want to see more data. We'll post again once we've had a chance to review the data in detail.